Braun Bostich & Associates Inc. Amgen Inc Transaction History

Braun Bostich & Associates Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $230,661 - $274,676	-1,066 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$234.65 - $260.95 $260,696 - $289,915	-1,111 Reduced 51.03%	1,066 $271,000
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $37,905 - $50,273	-208 Reduced 8.72%	2,177 $431,000
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $26,300 - $33,804	139 Added 6.19%	2,385 $573,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $57,630 - $69,053	331 Added 17.28%	2,246 $435,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $116,189 - $136,200	697 Added 57.22%	1,915 $353,000
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $158,803 - $179,006	878 Added 258.24%	1,218 $231,000
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $23,531 - $26,529	-127 Reduced 27.19%	340 $70,000
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $32,213 - $36,182	-194 Reduced 29.35%	467 $86,000
Q1 2018 May 16, 2018	SELL	$169.43 - $198.0 $229,577 - $268,290	-1,355 Reduced 67.21%	661 $0
Q4 2017 May 21, 2018	BUY	$168.79 - $188.59 $340,280 - $380,197	2,016	2,016 $351,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Braun Bostich & Associates Inc., based on Form 13F filings with the SEC.

Stay updated on Braun Bostich & Associates Inc. with notifications on news.